Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.
about
Antibiotic treatment of verocytotoxin-producing Escherichia coli (VTEC) infection: a systematic review and a proposalManagement strategies in the treatment of neonatal and pediatric gastroenteritisInvestigation of encephalopathy caused by Shiga toxin 2c-producing Escherichia coli infection in mice.Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotypeHaemolytic uraemic syndrome.Shiga toxin-producing Escherichia coli O104:H4: an emerging pathogen with enhanced virulenceRisk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control studyShigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies.Renal and neurological involvement in typical Shiga toxin-associated HUS.Carrier prevalence, secondary household transmission, and long-term shedding in 2 districts during the Escherichia coli O104:H4 outbreak in Germany, 2011.[Treatment of typical hemolytic-uremic syndrome. Knowledge gained from analyses of the 2011 E. coli outbreak].[Management of patients with EHEC/HUS. Lessons and perspectives from clinical infectious disease specialists].Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study.Symptoms and clinical course of EHEC O104 infection in hospitalized patients: a prospective single center studyCurrent evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome.Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab.Hemolytic uremic syndrome associated with Acinetobacter hemolyticus.Hypertension and mild chronic kidney disease persist following severe haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli O104:H4 in adults.Frequency of shiga toxin-producing genes of Escherichia coli isolated from diarrheic stools of Iranian children by PCRHaemolytic-uraemic syndrome with bacteraemia caused by a new hybrid Escherichia coli pathotype.Recent advances in understanding enteric pathogenic Escherichia coli.Intestinal decolonization of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBL): a retrospective observational study in patients at risk for infection and a brief review of the literature.Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain.Lessons Learned From Outbreaks of Shiga Toxin Producing Escherichia coliShiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.Capture of uropathogenic E. coli by using synthetic glycan ligands specific for the pap-pilus.Antimicrobial therapy of acute diarrhoea: a clinical review.Shiga Toxin-Producing Escherichia coli in Diarrheal Stool of Swedish Children: Evaluation of Polymerase Chain Reaction Screening and Duration of Shiga Toxin Shedding.[Gastrointestinal infections].Susceptibility of enterohaemorrhagic Escherichia coli to azithromycin in France and analysis of resistance mechanisms.Management of Food-Related Diarrhea Outbreak in the Emergency Department: Lessons Learned from the German STEC O104:H4 Epidemic.[Hemolytic anemia].Duration of shedding of Verocytotoxin-producing Escherichia coli in children and risk of transmission in childcare facilities in England.Acute diarrhoea due to a Shiga toxin 2e-producing Escherichia coli O8 : H19.Whole-genome sequencing for risk assessment of long-term Shiga toxin-producing Escherichia coli.Characteristics of clinical Shiga toxin-producing Escherichia coli isolated from British Columbia.[Drug therapy of infectious diarrhea: part 1: acute diarrhea].Public Health Research Resulting from One of the World's Largest Outbreaks Caused by Entero-Hemorrhagic Escherichia coli in Germany 2011: A Review.Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
P2860
Q26827657-174DA4CC-CD8F-4766-B7CE-CE2303BDF106Q27004496-1FF97FDB-CCAC-4D17-A97D-741ED352140AQ27334562-EBFDA01B-8ADE-4FC9-9A34-27044CF59DC5Q28087714-E0DCED21-95AB-42CB-99E7-82D820B23B84Q30244707-5C3EBE27-577D-444B-AF12-D211BA7011A0Q30411012-E1168DA1-7DF2-466A-B14C-3EC422B0C9BEQ33400310-A0293E95-F3EB-495F-BB58-03B7B3844D43Q33402456-1EEC7525-E50F-4FAF-89F0-BBADB62A78DCQ33402784-126A6AD0-A722-40F5-BE7A-42C93FC03D8AQ33403361-5A3684AB-8D97-49B6-B6E3-87C99DF7A466Q33404529-0C10A4E4-B26F-4F40-BE01-6F7930E7F906Q33404545-B9E1ACF6-EBFF-49D2-899A-72DBAE6A4858Q33405034-A47167F0-071B-40B1-BE38-7025D2E7797DQ33405183-A021F9E2-BFCC-429F-A34E-AD95CADFF3A3Q33406247-3351E2E3-D2F2-480E-9761-6203E3794CA0Q33409030-EB68AC8E-3DAD-4D6E-A019-2FE9DC2AE205Q33411810-D2554688-E9D6-44E5-B46D-4176DCD5E70FQ33415318-657AE523-8918-48AF-A2A1-33FF230CCD94Q33424483-E33BAA43-EFA4-46B8-A184-7EB93F03FC20Q33628277-0E8B9C56-99C0-467D-B0DE-44AB6E3F581DQ34286494-DCB53C40-1066-4918-8C05-E3201388F85DQ34375210-13E3ADC5-BC40-4AB2-96C8-E4CE170627ADQ35825390-BAD2AFD6-26B5-45EE-BFF5-79886DBCAE46Q36018770-E44CE9B4-AC70-468E-BCF9-7959AB1BC09EQ36563022-9A548865-F245-4B76-9400-7E231B52CED8Q36837884-B55BA541-AAC1-48C5-AA0F-1369351032F9Q38318624-8CE9206F-1028-433B-BE07-9BE36E1F258EQ38660838-30D2E8CE-47BF-47DC-ADCE-93A1BC2B94D0Q39751144-A260366E-7334-4906-9386-DE8A402B1E78Q40072061-6D12874D-2FF4-4607-9DA1-C3FE6284C70BQ40809851-D55367E3-D4B9-40E7-BBA6-A814AAE124FBQ40921773-17B15DB6-52EC-428B-9DAA-584CE1C5FECEQ41070320-F3F6AECB-B13D-4AAA-905B-01E48A0B571DQ42263143-D42DD52A-4A7F-48F0-9553-4A7B390FCC31Q42273840-70D1641B-E1B2-4B9B-B86D-F89104838D03Q42394070-234024C9-C6BF-4917-A0F2-32BCADFBFA23Q42935507-D622D635-6A5B-404D-8380-82956B4AE86FQ45022652-92B9252A-C7EB-496F-8F26-9122C8270E1BQ47295032-9430BE61-03B4-4F9A-8FC7-DFC78CCC1EF3Q49195473-5511C823-D2EA-40E6-87FB-C2F02D739A4A
P2860
Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Association between azithromyc ...... tive Escherichia coli O104:H4.
@ast
Association between azithromyc ...... tive Escherichia coli O104:H4.
@en
type
label
Association between azithromyc ...... tive Escherichia coli O104:H4.
@ast
Association between azithromyc ...... tive Escherichia coli O104:H4.
@en
prefLabel
Association between azithromyc ...... tive Escherichia coli O104:H4.
@ast
Association between azithromyc ...... tive Escherichia coli O104:H4.
@en
P2093
P356
P1476
Association between azithromyc ...... tive Escherichia coli O104:H4.
@en
P2093
Alexander Katalinic
Bettina Tiemer
Christoph Härtel
Friedhelm Sayk
Hendrik Lehnert
Inge Derad
Johannes K-M Knobloch
Jürgen Büning
Jürgen Steinhoff
P304
P356
10.1001/JAMA.2012.264
P407
P577
2012-03-01T00:00:00Z